Give Guidance to Manage Nonalcoholic Fatty Liver Disease
July 2022
You’ll see more focus on managing nonalcoholic fatty liver disease (NAFLD)...partly due to new guidelines.
It’s being called a “sleeper epidemic.” About 1 in 5 patients have this fat buildup in the liver...but most don’t have symptoms.
NAFLD often goes hand in hand with CV risk factors, such as insulin resistance or diabetes...obesity...and dyslipidemia.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive